| 16.57 Net Asset Value | +0.67% 1 Day | +22.56% Year-to-Date | Overall Morningstar Rating |
| Health Style or Category | No Load Sales Expenses | 1.16% Expense Ratio | Above Average Morningstar Risk Rating™ |
| 1 month | +5.07% | 3 years | +26.38% | |
| 3 months | +12.42% | 5 years | +15.44% | |
| 1 year | +40.56% | Since inception | +8.62% |
| VCHSX | Category | |
|---|---|---|
| Performance 5-yr return | +15.44% | +12.10% |
| Expense ratio | 1.16% | 1.55% |
| Risk 5 year sharpe ratio | 0.81 | 0.71 |
| Net assets | $397.1M | $1.5B |
| Average market cap | $9.0B | $19.4B |
| Average P/E | 23.8 | 21.6 |
| Portfolio turnover | 21% | 21% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
| Fund family | VALIC |
| Fund manager & tenure | Taymour Tamaddon / 0 Years |
| Minimal initial investment | $0.00 |
| Minimum IRA investment | -- |
| Other | 100.00% |
| U.S. stock | -- |
| International stock | -- |
| Fixed income | -- |
| Cash | -- |
| Healthcare | 93.57% |
| Consumer service | 1.09% |
| Industrial materials | 0.89% |
| Financial service | 0.35% |
| Hardware | 0.19% |
| GILD Gilead Sciences Inc | 5.08% |
| ALXN Alexion Pharmaceuticals, Inc. | 4.85% |
| -- Catamaran Corp | 4.21% |
| -- Valeant Pharmaceuticals International Inc | 2.95% |
| PCYC Pharmacyclics, Inc. | 2.74% |
| INCY Incyte Corp Ltd | 2.00% |
| UNH UnitedHealth Group Inc | 1.93% |
| CELG Celgene Corporation | 1.66% |
| REGN Regeneron Pharmaceuticals, Inc. | 1.64% |
| ONXX Onyx Pharmaceuticals, Inc. | 1.54% |
.
